Ethnic and gender differences in HPV knowledge, awareness, and vaccine acceptability among white and hispanic men and women

Journal of Community Health

Volumn 39, Issue 2, 2014, Pages 274-284

  Reimer, Rachel A ^a   Schommer, Julie A ^a   Houlihan, Amy E ^b   Gerrard, Meg ^c  

^a DES MOINES UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY CORPUS CHRISTI   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Gender differences; Health disparities; Hispanic health; HPV; HPV vaccination; Physician recommendation

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; AWARENESS; CAUCASIAN; ETHNOLOGY; FEMALE; HISPANIC; HUMAN; MALE; PAPILLOMAVIRUS INFECTION; PSYCHOLOGICAL ASPECT; SEX DIFFERENCE; SOCIOECONOMICS; YOUNG ADULT;

ADOLESCENT; ADULT; AWARENESS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HISPANIC AMERICANS; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; SEX FACTORS; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84896405112     PISSN: 00945145     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10900-013-9773-y     Document Type: Article

References (49)

1. Allen, J. D.; Othus, M. K.; Shelton, R. C.; Li, Y.; Norman, N.; Tom, L.; et al. (2010). Parental decision making about the HPV vaccine. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 19(9), 2187-2198. doi: 10.1158/1055-9965.EPI-10-0217.
2. Altekruse, S. F.; Kosary, C. L.; Krapcho, M.; Neyman, N.; Aminou, R.; Waldron, W.; et al. (2010). SEER cancer statistics review, 1975-2007. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975-2007/.
3. Baer, H.; Allen, S.; Braun, L. (2000). Knowledge of human papillomavirus infection among young adult men and women: Implications for health education and research. Journal of Community Health, 25(1), 67-78.
4. Barnholtz-Sloan, J.; Patel, N.; Rollison, D.; Kortepeter, K.; MackKinnon, J.; Giuliano, A. R. (2009). Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes and Control, 20(7), 1129-1138. doi: 10.1007/s10552-009-9317-z.
5. Boehner, C. W.; Howe, S. R.; Bernstein, D. I.; Rosenthal, S. L. (2003). Viral sexually transmitted disease vaccine acceptability among college students. Sexually Transmitted Diseases, 30(10), 774-778. doi: 10.1097/01.OLQ.0000078823. 05041.9E.
6. Brewer, N. T.; Fazekas, K. I. (2007). Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Preventive Medicine, 45(2-3), 107-114. doi: 10.1016/j.ypmed.2007.05.013.
7. Centers for Disease Control and Prevention. (2010). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report, 59(20), 630-632.
8. Centers for Disease Control and Prevention. (2012). Human papillomavirus-associated cancers-United States, 2004-2008. Morbidity and Mortality Weekly Report, 61(15), 258-261.
9. Centers for Disease Control and Prevention. (2012). National and state vaccination coverage among adolescents aged 13-17 years - United States 2011. Morbidity and Mortality Weekly Report, 61(34), 258-261.
10. Centers for Disease Control and Prevention. (2011). Recommendations on the use of quadrivalent human papillomavirus vaccine in males - Advisory Committee on Immunization Practices (ACIP). Morbidity Mortality Weekly Report, 60(50), 1705-1708.
11. Chaturvedi, A. K.; Engels, E. A.; Pfeiffer, R. M.; Hernandez, B. Y.; Xiao, W.; Kim, E.; et al. (2011). Human papillomavirus and rising oropharyngeal cancer incidence in the United States. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 29(32), 4294-4301. doi: 10.1200/JCO.2011.36.4596.
12. Colon-Lopez, V.; Ortiz, A. P.; Toro-Mejias, L. M.; Garcia, H.; Clatts, M. C.; Palefsky, J. (2012). Awareness and knowledge of human papillomavirus (HPV) infection among high-risk men of Hispanic origin attending a sexually transmitted infection (STI) clinic. BMC Infectious Diseases, 12, 346. doi: 10.1186/1471-2334-12-346.
13. Daley, M. F.; Liddon, N.; Crane, L. A.; Beaty, B. L.; Barrow, J.; Babbel, C.; et al. (2006). A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics, 118(6), 2280-2289. doi: 10.1542/peds.2006-1946.
14. Davis, K.; Dickman, E. D.; Ferris, D.; Dias, J. K. (2004). Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. Journal of Lower Genital Tract Disease, 8(3), 188-194.
15. Dempsey, A. F.; Zimet, G. D.; Davis, R. L.; Koutsky, L. (2006). Factors that are associated with parental acceptance of human papillomavirus vaccines: A randomized intervention study of written information about HPV. Pediatrics, 117(5), 1486-1493. doi: 10.1542/peds.2005-1381.
16. Downs, L. S.; Smith, J. S.; Scarinci, I.; Flowers, L.; Parham, G. (2008). The disparity of cervical cancer in diverse populations. Gynecologic Oncology, 109(2 Suppl), S22-S30. doi: 10.1016/j.ygyno.2008.01.003.
17. Duggan, C.; Coronado, G.; Martinez, J.; Byrd, T. L.; Carosso, E.; Lopez, C.; et al. (2012). Cervical cancer screening and adherence to follow-up among Hispanic women study protocol: A randomized controlled trial to increase the uptake of cervical cancer screening in Hispanic women. BMC Cancer, 12, 170. doi: 10.1186/1471-2407-12-170.
18. Dunne, E. F.; Nielson, C. M.; Stone, K. M.; Markowitz, L. E.; Giuliano, A. R. (2006). Prevalence of HPV infection among men: A systematic review of the literature. The Journal of Infectious Diseases, 194(8), 1044-1057. doi: 10.1086/507432.
19. Dunne, E. F.; Unger, E. R.; Sternberg, M.; McQuillan, G.; Swan, D. C.; Patel, S. S.; et al. (2007). Prevalence of HPV infection among females in the United States. JAMA, the Journal of the American Medical Association, 297(8), 813-819. doi: 10.1001/jama.297.8.813.
20. Ferris, D. G.; Waller, J. L.; Miller, J.; Patel, P.; Price, G. A.; Jackson, L.; et al. (2009). Variables associated with human papillomavirus (HPV) vaccine acceptance by men. Journal of the American Board of Family Medicine: JABFM, 22(1), 34-42. doi: 10.3122/jabfm.2009.01.080008.
21. Friedman, A. L.; Shepeard, H. (2007). Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: Findings from CDC focus group research and implications for practice. Health Education & Behavior: The Official Publication of the Society for Public Health Education, 34(3), 471-485. doi: 10.1177/1090198106292022.
22. Gerend, M. A.; Lee, S. C.; Shepherd, J. E. (2007). Predictors of human papillomavirus vaccination acceptability among underserved women. Sexually Transmitted Diseases, 34(7), 468-471. doi: 10.1097/01.olq.0000245915.38315.bd.
23. Gerend, M. A.; Magloire, Z. F. (2008). Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine, 42(3), 237-242. doi: 10.1016/j.jadohealth.2007.08.022.
24. Gerend, M. A.; Shepherd, J. E. (2011). Correlates of HPV knowledge in the era of HPV vaccination: A study of unvaccinated young adult women. Women and Health, 51(1), 25-40. doi: 10.1080/03630242.2011.540744.
25. Gilbert, P. A.; Brewer, N. T.; Reiter, P. L. (2011). Association of human papillomavirus-related knowledge, attitudes, and beliefs with HIV status: A national study of gay men. Journal of Lower Genital Tract Disease, 15(2), 83-88. doi: 10.1097/LGT.0b013e3181f1a960.
26. Griffioen, A. M.; Glynn, S.; Mullins, T. K.; Zimet, G. D.; Rosenthal, S. L.; Fortenberry, J. D.; et al. (2012). Perspectives on decision making about human papillomavirus vaccination among 11- to 12-year-old girls and their mothers. Clinical Pediatrics, 51(6), 560-568. doi: 10.1177/0009922812443732.
27. Hoover, D. R.; Carfioli, B.; Moench, E. A. (2000). Attitudes of adolescent/young adult women toward human papillomavirus vaccination and clinical trials. Health Care for Women International, 21(5), 375-391. doi: 10.1080/07399330050082227.
28. Jaccard, J. J. (2001). Interaction effects in logistic regression. Quantitative applications in the social sciences (series 135). Newbury Park, CA: Sage.
29. Jain, N.; Euler, G. L.; Shefer, A.; Lu, P.; Yankey, D.; Markowitz, L. (2009). Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Preventive Medicine, 48(5), 426-431. doi: 10.1016/j.ypmed.2008.11.010.
30. Janicki, D. L.; Kamarck, T. W.; Shiffman, S.; Sutton-Tyrrell, K.; Gwaltney, C. J. (2005). Frequency of spousal interaction and 3-year progression of carotid artery intima medial thickness: The Pittsburgh healthy heart project. Psychosomatic Medicine, 67(6), 889-896. doi: 10.1097/01.psy.0000188476.87869. 88.
31. Kahn, J. A.; Lan, D.; Kahn, R. S. (2007). Sociodemographic factors associated with high-risk human papillomavirus infection. Obstetrics and Gynecology, 110(1), 87-95. doi: 10.1097/01.AOG.0000266984.23445.9c.
32. Katz, M. L.; Krieger, J. L.; Roberto, A. J. (2011). Human papillomavirus (HPV): College male's knowledge, perceived risk, sources of information, vaccine barriers and communication. Journal of Men's Health, 8(3), 175-184. doi: 10.1016/j.jomh.2011.04.002.
33. Kiecolt-Glaser, J. K.; Newton, T. L. (2001). Marriage and health: His and hers. Psychological Bulletin, 127(4), 472-503.
34. Liddon, N.; Hood, J.; Wynn, B. A.; Markowitz, L. E. (2010). Acceptability of human papillomavirus vaccine for males: A review of the literature. The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine, 46(2), 113-123. doi: 10.1016/j.jadohealth.2009.11.199.
35. Markowitz, L. E.; Dunne, E.; Saraiya, M.; Lawson, H. J.; Chesson, H.; Unger, E. (2007). Centers for Disease Control and Prevention: Quadrivalent human papillomavirus vaccine from the recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report, 56, 1-24.
36. Myers, E. R.; McCrory, D. C.; Nanda, K.; Bastian, L.; Matchar, D. B. (2000). Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. American Journal of Epidemiology, 151(12), 1158-1171.
37. Nandwani, M. C. (2010). Men's knowledge of the human papillomavirus vaccine. The Nurse Practitioner, 35(11), 32-39. doi: 10.1097/01.NPR.0000388900. 49604.e1.
38. Pagliusi, S. (2010). World Health Organization. Accessed January 23, 2013, http://www.who.int/vaccines/en/dpvrd.shtml.
39. Reimer, R. A.; Houlihan, A. E.; Gerrard, M.; Deer, M. M.; Lund, A. J. (2012). Ethnic differences in predictors of HPV vaccination: Comparisons of predictors for Latina and non-Latina White women. Journal of Sex Research,. doi: 10.1080/00224499.2012.692406.
40. Reiter, P. L.; McRee, A. L.; Gottlieb, S. L.; Brewer, N. T. (2010). HPV vaccine for adolescent males: Acceptability to parents post-vaccine licensure. Vaccine, 28(38), 6292-6297. doi: 10.1016/j.vaccine.2010.06.114.
41. Reiter, P. L.; McRee, A. L.; Kadis, J. A.; Brewer, N. T. (2011). HPV vaccine and adolescent males. Vaccine, 29(34), 5595-5602. doi: 10.1016/j.vaccine.2011.06.020.
42. Ries, L. A. G.; Eisner, M. P.; Kosary, C. L.; Hankey, B. F.; Miller, B. A.; Mariotto, A.; et al. (2002). SEER cancer statistics review, 1975-2002. National Cancer Institute Bethesda, MD. http://seer.cancer.gov/csr/1975-2002/.
43. Roberts, M. E.; Gerrard, M.; Reimer, R.; Gibbons, F. X. (2010). Mother-daughter communication and human papillomavirus vaccine uptake by college students. Pediatrics, 125(5), 982-989. doi: 10.1542/peds.2009-2888.
44. Rosenthal, S. L.; Weiss, T. W.; Zimet, G. D.; Ma, L.; Good, M. B.; Vichnin, M. D. (2011). Predictors of HPV vaccine uptake among women aged 19-26: Importance of a physician's recommendation. Vaccine, 29(5), 890-895. doi: 10.1016/j.vaccine.2009.12.063.
45. Satterwhite, C. L.; Torrone, E.; Meites, E.; Dunne, E. F.; Mahajan, R.;. Weinstock, H. (2013). Sexually transmitted infections among US women and men: Prevalence and incidence estimates, 2008. Sexually Transmitted Diseases, 40(3), 187-193.
46. Stock, M. L.; Peterson, L. M.; Houlihan, A. E.; Walsh, L. A. (2013). Influence of oral sex and oral cancer information on young adults' oral sexual-risk cognitions and likelihood of HPV vaccination. Journal of Sex Research, 50(1), 95-102. doi: 10.1080/00224499.2011.642904.
47. U.S. Food and Drug Administration. (2006). FDA licenses new vaccine for prevention of cervical cancer and other diseases in females caused by human papillomavirus. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ ucm108666.htm.
48. Watson, M.; Saraiya, M.; Benard, V.; Coughlin, S. S.; Flowers, L.; Cokkinides, V.; et al. (2008). Burden of cervical cancer in the United States, 1998-2003. Cancer, 113(10 Suppl), 2855-2864. doi: 10.1002/cncr.23756.
49. Zimet, G. D.; Mays, R. M.; Winston, Y.; Kee, R.; Dickes, J.; Su, L. (2000). Acceptability of human papillomavirus immunization. Journal of Women's Health & Gender-Based Medicine, 9(1), 47-50. doi: 10.1089/152460900318957.